Collplant Biotechnologies Ltd
NASDAQ:CLGN
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Price:
0.6799
USD
1.93%
Market Closed
Market Cap:
$8.7m
Balance Sheet
Balance Sheet Decomposition
Collplant Biotechnologies Ltd
Collplant Biotechnologies Ltd
Balance Sheet Decomposition is not available for
Collplant Biotechnologies Ltd
Collplant Biotechnologies Ltd
Balance Sheet
Collplant Biotechnologies Ltd
Collplant Biotechnologies Ltd
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
4
|
3
|
43
|
30
|
27
|
12
|
|
| Cash |
0
|
0
|
0
|
30
|
0
|
0
|
0
|
|
| Cash Equivalents |
5
|
4
|
3
|
13
|
30
|
27
|
12
|
|
| Total Receivables |
1
|
0
|
1
|
1
|
1
|
0
|
1
|
|
| Accounts Receivables |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
7
|
5
|
6
|
45
|
32
|
28
|
13
|
|
| PP&E Net |
1
|
6
|
5
|
6
|
6
|
6
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
6
|
6
|
6
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
4
|
5
|
6
|
7
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
11
+23%
|
11
+1%
|
51
+373%
|
38
-26%
|
34
-10%
|
19
-45%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
3
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
3
|
3
|
3
|
2
|
3
|
2
|
|
| Total Liabilities |
3
N/A
|
7
+100%
|
6
-5%
|
6
-4%
|
5
-10%
|
6
+5%
|
5
-9%
|
|
| Equity | ||||||||
| Common Stock |
2
|
2
|
3
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
56
|
67
|
73
|
73
|
90
|
97
|
113
|
|
| Additional Paid In Capital |
61
|
70
|
76
|
114
|
118
|
121
|
123
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
5
N/A
|
4
-25%
|
4
+10%
|
45
+907%
|
32
-28%
|
28
-12%
|
13
-52%
|
|
| Total Liabilities & Equity |
9
N/A
|
11
+23%
|
11
+1%
|
51
+373%
|
38
-26%
|
34
-10%
|
19
-45%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
6
|
7
|
11
|
11
|
11
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
